Clinical trial
A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In…
NCT00353808 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00353808 |
|---|---|
| Title | A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain. |
| Official title | An Open-Label Extension Trial Assessing The Safety And Tolerability Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN). |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | [S, S]-Reboxetine |
| Enrollment | 112 |
| Start date | Jul 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Jul 19, 2006 |
| Last update posted | Apr 7, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: